Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Absci Corporation (ABSI) Insider Trading Activity
Healthcare • Biotechnology • 155 employees
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. It has a collaboration with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using generative AI; and with AstraZeneca PLC for AI-driven drug discovery against an oncology target. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Total Value
-$244,359.74
Total Shares
307,847
Average Trade Value
-$16,290.65
Most Active Insider
Mc Clain Sean
Total Activity: $132,227
Largest Single Transaction
$63,516
by Bedrick Todd on Oct 12, 2024
30-Day Activity
6 Transactions
Volume: 379,181 shares
Value: $28,915
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Svp, Cao
Officer
|
Mar 3, 2025 | 29,700 | $10,000 | 167,827 (+17.7%) | Grant | |
|
Chief Innovation Officer
Officer
|
Mar 3, 2025 | 23,700 | $10,000 | 277,264 (+8.5%) | Grant | |
|
CFO / Cbo
Officer
|
Mar 3, 2025 | 81,500 | $10,000 | 423,254 (+19.3%) | Grant | |
|
Chief Executive Officer
Director, Officer
|
Mar 3, 2025 | 190,200 | $10,000 | 8,384,621 (+2.3%) | Grant | |
|
Chief Legal Officer
Officer
|
Mar 3, 2025 | 59,300 | $10,000 | 59,300 (+100.0%) | Grant | |
|
CFO / Cbo
Officer
|
Feb 28, 2025 | 5,219 | $21,085 | 341,754 (-1.5%) | Payment of Exercise Price | |
|
Chief Executive Officer
Director, Officer
|
Feb 1, 2025 | 16,991 | $63,037 | 8,194,421 (-0.2%) | Payment of Exercise Price | |
|
Svp, Cao
Officer
|
Feb 1, 2025 | 2,630 | $9,757 | 138,127 (-1.9%) | Payment of Exercise Price | |
|
Chief Innovation Officer
Officer
|
Feb 1, 2025 | 1,469 | $5,450 | 253,564 (-0.6%) | Payment of Exercise Price | |
|
CFO / Cbo
Officer
|
Feb 1, 2025 | 11,567 | $42,914 | 346,973 (-3.3%) | Payment of Exercise Price | |
|
CFO / Cbo
Officer
|
Nov 30, 2024 | 5,194 | $15,842 | 358,540 (-1.4%) | Payment of Exercise Price | |
|
CFO / Cbo
Officer
|
Oct 12, 2024 | 242 | $985 | 363,734 (-0.1%) | Payment of Exercise Price | |
|
Chief Innovation Officer
Officer
|
Oct 12, 2024 | 3,092 | $12,584 | 255,033 (-1.2%) | Payment of Exercise Price | |
|
Svp, Cao
Officer
|
Oct 12, 2024 | 15,606 | $63,516 | 139,064 (-11.2%) | Payment of Exercise Price | |
|
Chief Executive Officer
Director, Officer
|
Oct 12, 2024 | 14,543 | $59,190 | 8,211,412 (-0.2%) | Payment of Exercise Price |